Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism
Bergqvist, D.
Lakartidningen 87(8): 562-564
1990
ISSN/ISBN: 0023-7205 PMID: 2155361 Document Number: 359461
Document emailed within 1 workday
Related Documents
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332
Couturaud, F.; Julian, J.A.; Kearon, C. 2001: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis Thrombosis and Haemostasis 86(4): 980-984
Mcgarry, L.J.; Thompson, D. 2004: Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice Clinical Therapeutics 26(3): 419-430
Caprini, J.A.; Arcelus, J.; Sehgal, L.R.; Cohen, E.B.; Reyna, J.J. 2002: The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States International Angiology: a Journal of the International Union of Angiology 21(1): 78-85
Heit, J.A.; Berkowitz, S.D.; Bona, R.; Cabanas, V.; Corson, J.D.; Elliott, C.G.; Lyons, R. 1997: Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group Thrombosis and Haemostasis 77(1): 32-38
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Kakkar, V.V.; Bentley, P.G.; Lawrence, D.; de Haas, H.A.; Ward, V.P. 1979: Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement Münchener Medizinische Wochenschrift 121(36): 1152-1154
Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Matsagas, M.I. 2004: Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview International Angiology: a Journal of the International Union of Angiology 23(4): 305-316
Vallano, A.; Arnau, J.M.; Vallés, J.A. 1991: Prophylaxis of venous thrombosis and low-molecular-weight heparin Medicina Clinica 97(7): 272-275
Broyer, M.; Gagnadoux, M.F.; Sierro, A.; Fischer, A.M.; Niaudet, P. 1991: Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin Transplantation Proceedings 23(1 Pt 2): 1384-1385
Tapson, V.F.; Hull, R.D. 1995: Management of venous thromboembolic disease. the impact of low-molecular-weight heparin Clinics in Chest Medicine 16(2): 281-294
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Pindur, G.; Köhler, M.; Heiden, M.; Leipnitz, C.; Rupp, K.H.; Wenzel, E. 1990: Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1149-1155
Baca, I.; Schneider, B.; Köhler, T.; Misselwitz, F.; Zehle, A.; Mühe, F. 1997: Prevention of thromboembolism in minimal invasive interventions and brief inpatient treatment. Results of a multicenter, prospective, randomized, controlled study with a low molecular weight heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 68(12): 1275-1280
Bacher, P.; Horst, B.; Breyer, H.G.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients Seminars in Thrombosis and Hemostasis 19(Suppl 1): 73-78
Stephan, D.; Welsch, M.; Chapatte, D.; Weltin, D.; Imbs, J.L. 1999: Deep venous thrombosis during pregnancy: long-term treatment with low molecular weight heparin Presse Medicale 28(34): 1880
Lamy, O.; Cornuz, J.; Yersin, B. 1999: Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review Schweizerische Medizinische Wochenschrift 129(18): 707-714
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839